ACTIONS OF FLUPENTHIXOL UPON 5-HYDROXYTRYPTAMINE-INDUCED AGGREGATION AND UPTAKE OF 5-HYDROXYTRYPTAMINE AND DOPAMINE BY HUMAN-BLOOD PLATELETS

被引:9
作者
BOULLIN, DJ
GRIMES, RPJ
ORR, MW
机构
[1] UNIV OXFORD,MRC UNIT,WOODSTOCK RD,OXFORD OX2 6HE,ENGLAND
[2] UNIV OXFORD,RADCLIFFE INFIRM,DEPT CLIN PHARMACOL,OXFORD OX2 6HE,ENGLAND
关键词
D O I
10.1111/j.1476-5381.1975.tb07432.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:555 / 557
页数:3
相关论文
共 11 条
[1]   RELATIVE ACTIVITIES ON AND UPTAKE BY HUMAN BLOOD-PLATELETS OF 5-HYDROXYTRYPTAMINE AND SEVERAL ANALOGS [J].
BORN, GVR ;
JUENGJAROEN, K ;
MICHAL, F .
BRITISH JOURNAL OF PHARMACOLOGY, 1972, 44 (01) :117-+
[2]   INCREASED PLATELET-AGGREGATION RESPONSES TO 5-HYDROXYTRYPTAMINE IN PATIENTS TAKING CHLORPROMAZINE [J].
BOULLIN, DJ ;
WOODS, HF ;
GRIMES, RPJ ;
GRAHAMESMITH, DG ;
WILES, D ;
GELDER, MG ;
KOLAKOWSKA, T .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 2 (01) :29-35
[3]   INHIBITION OF 5-HYDROXYTRYPTAMINE-INDUCED HUMAN-BLOOD PLATELET-AGGREGATION BY CHLORPROMAZINE AND ITS METABOLITES [J].
BOULLIN, DJ ;
GRAHAMESMITH, DG ;
GRIMES, RPJ ;
WOODS, HF .
BRITISH JOURNAL OF PHARMACOLOGY, 1975, 53 (01) :121-125
[4]   ACCUMULATION OF DOPAMINE BY BLOOD PLATELETS FROM NORMAL SUBJECTS AND PARKINSONIAN PATIENTS UNDER TREATMENT WITH L-DOPA [J].
BOULLIN, DJ ;
OBRIEN, RA .
BRITISH JOURNAL OF PHARMACOLOGY, 1970, 39 (04) :779-&
[5]   MECHANISM OF ADENOSINE-DIPHOSPHATE INDUCED PLATELET AGGREGATION - BINDING TO PLATELET RECEPTORS AND INHIBITION OF BINDING AND AGGREGATION BY PROSTAGLANDIN-E1 [J].
BOULLIN, DJ ;
GREEN, AR ;
PRICE, KS .
JOURNAL OF PHYSIOLOGY-LONDON, 1972, 221 (02) :415-&
[6]  
BYGDEMAN S, 1971, 2 P C INT SOC THROMB, V182
[7]   INTERACTION OF NEUROLEPTIC AND MUSCARINIC AGENTS WITH CENTRAL DOPAMINERGIC SYSTEMS [J].
KELLY, PH ;
MILLER, RJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1975, 54 (01) :115-121
[8]  
MILLER RJ, 1974, MOL PHARMACOL, V10, P759
[9]   MEMBRANE ACTIVE DRUGS AND AGGREGATION OF HUMAN BLOOD PLATELETS [J].
MILLS, DCB ;
ROBERTS, GCK .
NATURE, 1967, 213 (5071) :35-&
[10]  
MOLLERNIELSEN I, 1973, ACTA PHARMACOL TOX, V33, P353